Move to reschedule codeine

Regulators are being asked to consider whether codeine preparations should move to prescription-only status.

The July meeting of the TGA’s Advisory Committee on Medicines Scheduling is to consider the following amendment: “To delete the Schedule 3 entry for codeine, and reschedule the current Schedule 3 codeine entry to Schedule 4 due to potential issues of morbidity, toxicity and dependence”.

The committee is also being asked to consider “whether all current Schedule 3 preparations should be rescheduled to Schedule 4, or whether any